Kramer Kelly A. sold GILD
November 28, 2025 · Form 4 insider transaction
Kramer Kelly A. sold 2,805 shares of Gilead Sciences, Inc. at $127.10 per share, a transaction worth $356.5K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 3 days after the transaction.
Direction
Disposed (sell-side)
Shares
2,805
Price
$127.10
Total value
$356.5K
InsiderKramer Kelly A.
RoleDirector
CompanyGilead Sciences, Inc. (GILD)
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateNovember 28, 2025
Filing dateDecember 1, 2025
Shares owned after1,339
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
The transaction reported in this Form 4 is made pursuant to a Rule 10b5-1 trading plan adopted on August 27, 2025.